l.parkinson

TL2 Member · Lublin, PL

Practical questions, practical answers. Not interested in speculation without a source.

Joined 12 January 2025 · last posted 6h

95 posts, newest first. Showing up to 150.

Sulfonylureas: the interaction most worth taking seriously Replied, post #9 · Practice › Interactions · 28 Jul 2026 · 21 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #32 · Lounge › Off topic · 23 Jul 2026 · 0 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. I would be…
What is genuinely unknown about long-term amylin agonism Replied, post #54 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2026 · 11 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #109 · Evidence › Journal club · 15 Jul 2026 · 19 likes I would put moderate confidence on the mainstream reading of SURMOUNT-OSA and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #119 · Evidence › Journal club · 13 Jul 2026 · 9 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #52 · Practice › Dosing & titration · 10 Jul 2026 · 18 likes Taking post #50 at face value and following it one step further. The most common practical error is not the schedule at all — it is losing track of which step you are…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #30 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 23 likes Building on post #27 rather than restating it. Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #60 · Analytics › Impurities & related substances · 9 Jul 2026 · 5 likes Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather than in the chromatogram. Conflating the two accounts for several…
A critique that turned out to be unfair, retracted by its author Replied, post #26 · Evidence › Study critique · 8 Jul 2026 · 20 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Generalisability and validity are separate axes. A trial can be internally…
Tracking a shortage from primary sources rather than rumour Replied, post #78 · Access › Shortages · 1 Jul 2026 · 0 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
Journal club: what we got wrong in an earlier session Replied, post #22 · Evidence › Journal club · 23 Jun 2026 · 15 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. It is one…
Follow-up: Reading an interaction checker output critically Replied, post #13 · Practice › Interactions · 21 Jun 2026 · 3 likes Taking post #12 at face value and following it one step further. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
I joined for one answer and stayed for a year — what changed my mind Replied, post #31 · Start Here › Welcome · 19 Jun 2026 · 21 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
What steady state means for the decision to escalate Replied, post #15 · Practice › Dosing & titration · 17 Jun 2026 · 3 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Electrolyte supplements: which ones do anything Replied, post #30 · Nutrition & Training › Hydration & electrolytes · 14 Jun 2026 · 0 likes Everything in post #26 holds. The case it does not cover is the one I have. Second-hand on electrolyte supplements, so weight it accordingly — someone whose method I…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2026 · 30 likes Post #2 and I disagree about the size of the effect, not about the direction. Cagrilintide alone came up in a thread eighteen months ago and was answered well. I cannot…
A comparison of home results against a laboratory result on the same vial — does this… Replied, post #5 · Analytics › Home & field testing · 6 Jun 2026 · 3 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #60 · Practice › Storage & stability · 2 Jun 2026 · 3 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #65 · Practice › Reconstitution · 31 May 2026 · 4 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
Research-use-only status: what it means legally and practically Replied, post #50 · Compounds › Other compounds · 30 May 2026 · 0 likes The number people quote for research-use-only status is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #47 · Safety › Contraindications · 22 May 2026 · 2 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Revisiting: Mobile reading experience on long topics Replied, post #6 · Meta › Site feedback · 15 May 2026 · 0 likes On post #2 — agreed on the reasoning, with one qualification. Agreed, and it matters most on old topics where the person who asked has not been back in two years. The…
Prescription requirements and telehealth models — a second dataset Replied, post #28 · Sourcing › Regulatory · 13 May 2026 · 32 likes That reframing is the whole thing. The facts I already had.
Anaesthesia and elective surgery: the aspiration question Replied, post #96 · Practice › Interactions · 22 Apr 2026 · 14 likes Confirming post #93 from a second method, which matters more than confirming it from a second person. I would call the community position on anaesthesia and elective…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #51 · Evidence › Trials · 19 Apr 2026 · 7 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Publication bias detection and its low power — does this still hold? Replied, post #24 · Evidence › Meta-analyses · 16 Apr 2026 · 23 likes Seconded. It reads as careful rather than confident, which is the right register.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #93 · Lounge › Introductions · 17 Mar 2026 · 16 likes Glad to see another member from outside the usual regions. The access and regional categories are thin for anywhere that is not the UK, EU or North America, and a dated…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #58 · Practice › Storage & stability · 8 Mar 2026 · 12 likes Having read the whole Adsorptive losses thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
Stepping down deliberately, and how to do it without losing progress Replied, post #64 · Practice › Dosing & titration · 25 Feb 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Severe abdominal pain: why this is not a forum question Replied, post #2 · Safety › Adverse events · 25 Feb 2026 · 15 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
Pharmacy supply in the UK and the questions you will be asked Replied, post #49 · Regional › UK & Ireland · 21 Feb 2026 · 3 likes Filing a mild objection to the consensus on pharmacy supply. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #121 · Compounds › Semaglutide · 16 Feb 2026 · 0 likes Narrowing post #120, because the general version has more than one answer. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer.…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #37 · Start Here › Welcome · 31 Jan 2026 · 1 like There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #54 · Sourcing › Regulatory · 29 Jan 2026 · 32 likes Practical answer on compound being unapproved, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether…
A partial dose because the pen emptied mid-injection Replied, post #34 · Practice › Administration · 8 Jan 2026 · 7 likes Post #30 and I disagree about the size of the effect, not about the direction. On partial dose because the pen, the part that usually goes wrong is that the question is…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #12 · Practice › Side effects · 1 Jan 2026 · 1 like The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #7 · Practice › Storage & stability · 26 Dec 2025 · 0 likes Reporting rather than recommending, on Adsorptive losses. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Second pass at: The topic list is dense — is that deliberate? Replied, post #27 · Meta › Site feedback · 24 Dec 2025 · 2 likes Not a bug, but worth saying: the moderation log is paginated at twenty-five entries and there is no way to filter it by rule. Being able to read every R6 action in…
Tracking a preprint to publication: a worked example Replied, post #111 · Evidence › Preprints · 11 Dec 2025 · 31 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it. A…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #36 · Documentation › Doc review · 4 Dec 2025 · 5 likes This settles it for me, at least until somebody posts a reason it should not.
How to read a forest plot, properly, from scratch Replied, post #59 · Evidence › Trials · 22 Nov 2025 · 4 likes Post #56 is right about the mechanism and I think understates the practical bit. Absolute and relative effects answer different questions. Write down the event rate in…
Why "add 2 mL" is not an instruction Replied, post #9 · Practice › Reconstitution · 18 Nov 2025 · 16 likes Post #8 describes the usual case. This is about the unusual one. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
What a purity-only report leaves out Replied, post #89 · Sourcing › Independent verification · 16 Nov 2025 · 24 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
Why oral semaglutide needs an absorption enhancer at all Replied, post #50 · Compounds › Oral incretins · 15 Nov 2025 · 14 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #8 · Data & Tools › Calculators · 14 Nov 2025 · 13 likes Checking a tool against a worked example you already trust is five minutes well spent, and it is the only validation available to a user. I am not the right person to…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #86 · Start Here › Welcome · 20 Oct 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #23 · Compounds › Tirzepatide · 19 Oct 2025 · 12 likes Picking up post #22: that is the part I would want checked first. Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth…
Lyophilisation and why the cake looks the way it does Replied, post #19 · Pharmacology › Formulation chemistry · 6 Oct 2025 · 3 likes What I would want before treating lyophilisation as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #106 · Evidence › Study critique · 16 Sep 2025 · 2 likes Useful. I have added it to my own notes with the date on it.
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #20 · Compounds › Tirzepatide · 15 Sep 2025 · 9 likes Useful. I had the fact and not the reason, which turns out to be the important half.
What this community means by "a source", in practical terms Replied, post #108 · Start Here › Welcome · 11 Sep 2025 · 10 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #57 · Practice › Side effects · 27 Aug 2025 · 10 likes Taking post #54 at face value and following it one step further. Genuine question rather than a rhetorical one: has anyone here actually observed Fatigue, as opposed to…
Coming back to: Why quantitation is the hard part, not detection Replied, post #55 · Analytics › Home & field testing · 23 Aug 2025 · 0 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.
Immortal time bias in a claims-database study Replied, post #23 · Evidence › Study critique · 17 Aug 2025 · 5 likes I read post #19 twice before replying, because I had assumed the opposite. Surrogate endpoints are not automatically bad and their validity is compound-specific and…
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #32 · Analytics › HPLC & UHPLC · 13 Aug 2025 · 0 likes Post #29 is right about the mechanism and I think understates the practical bit. Particle size and column dimensions determine what resolution is achievable at all. A 5…
Coming back to: Cross-border purchase rules within the EU Replied, post #16 · Regional › European Union · 12 Aug 2025 · 16 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
Which panel is worth repeating and which is worth ignoring Replied, post #82 · Clinical › Bloodwork · 11 Aug 2025 · 0 likes Adding the measurement that post #81 says would settle it. Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A…
Are there stupid questions here? A staff answer, at length Replied, post #52 · Start Here › Welcome · 8 Aug 2025 · 30 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
Travel coolers and how long they really hold Replied, post #55 · Devices › Cold chain · 5 Aug 2025 · 19 likes No disagreement from me. Posting only so the question does not look ignored.
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #23 · Compounds › Retatrutide · 25 Jul 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Titles that describe the question, not the situation Replied, post #54 · Start Here › How to Ask · 22 Jul 2025 · 12 likes I had written a reply contradicting post #50 and deleted it. Here is what survived. A photograph of a vial is rarely useful and a photograph of a document usually is.…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 0 likes Picking up post #22: that is the part I would want checked first. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
An emergency department visit, described afterwards Replied, post #38 · Safety › Adverse events · 4 Jul 2025 · 22 likes Right — I had this wrong and I am glad to have read it before it mattered.
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #52 · Compounds › Oral incretins · 23 Jun 2025 · 13 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #131 · Practice › Reconstitution · 10 Jun 2025 · 28 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
Journal club: SURMOUNT-1, read without the press release Replied, post #131 · Evidence › Journal club · 5 Jun 2025 · 1 like Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
A supplier that answers analytical questions with restated claims Replied, post #86 · Sourcing › Red flags · 29 May 2025 · 4 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers.
Antibiotics and a course of something with delayed emptying Replied, post #51 · Practice › Interactions · 28 May 2025 · 12 likes On antibiotics I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #22 · Compounds › Repair & healing peptides · 25 May 2025 · 4 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
Pregnancy as an absolute contraindication Replied, post #102 · Safety › Contraindications · 20 May 2025 · 18 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Requesting a translation of an existing page Replied, post #15 · Documentation › Wiki requests · 7 May 2025 · 0 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion. The conclusion is tentative; the…
A well-designed study with a badly written abstract Replied, post #52 · Evidence › Study critique · 30 Apr 2025 · 10 likes Well-designed study is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Metformin co-administration and additive GI effects Replied, post #20 · Practice › Interactions · 28 Apr 2025 · 1 like A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #34 · Compounds › Repair & healing peptides · 14 Apr 2025 · 0 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #37 · Compounds › Tirzepatide · 9 Apr 2025 · 10 likes Confirming post #34 from a second method, which matters more than confirming it from a second person. Titration schedules for tirzepatide have more dose steps than…
Consistent declarations and why they matter more than clever ones Replied, post #156 · Sourcing › Logistics · 9 Mar 2025 · 0 likes Post #155 is right about the mechanism and I think understates the practical bit. An honest declaration on consistent declarations: I have a prior here and it is strong…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #157 · Sourcing › Regulatory · 6 Mar 2025 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. If the premise is…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #117 · Sourcing › Regulatory · 4 Mar 2025 · 8 likes Where I part company with post #115, and it is a narrow parting. Posting my pharmaceutical compounding rules numbers with the method attached so they can be discounted…
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #42 · Documentation › Doc review · 2 Mar 2025 · 4 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. I have changed my mind on…
An orphaned page with no inbound links Replied, post #8 · Meta › Wiki maintenance · 12 Feb 2025 · 0 likes Practical note on orphaned page: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Research-use-only status: what it means legally and practically — a second dataset Replied, post #65 · Compounds › Other compounds · 16 Jan 2025 · 1 like Worth separating Research-use-only status as a question about the compound from Research-use-only status as a question about the documentation. They get answered by…
UK access routes, dated and sourced — a second dataset Replied, post #26 · Regional › UK & Ireland · 12 Jan 2025 · 27 likes Everything in post #24 holds. The case it does not cover is the one I have. Members outside these two jurisdictions reading this thread should note that none of it…
[2026 update] New subcategory: rationale and scope Replied, post #126 · Meta › Announcements · 6 Jan 2025 · 17 likes No notes. Posting so the count is not one.
Building a sensible monitoring schedule with your prescriber Replied, post #24 · Clinical › Bloodwork · 19 Dec 2024 · 1 like Posting my building a sensible monitoring schedule numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by…
Washout with a one-week half-life: the arithmetic Replied, post #38 · Research Methods › N-of-1 designs · 29 Nov 2024 · 14 likes I would call the community position on washout likely rather than established, and I would be comfortable defending that hedge.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #124 · Clinical › Comorbidities · 29 Oct 2024 · 8 likes The version of Hypertension improvement that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
Why I ask for the gradient before I discuss the number Replied, post #28 · Analytics › HPLC & UHPLC · 16 Oct 2024 · 0 likes Particle size and column dimensions determine what resolution is achievable at all. A 5 micrometre 250 millimetre column and a sub-2 micrometre 100 millimetre column…
Requesting a page: what makes a good request — what changed since Replied, post #121 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #98 · Clinical › Bloodwork · 10 Oct 2024 · 13 likes Where I part company with post #94, and it is a narrow parting. Where I have landed on bring a laboratory, having got it wrong once in public: the direction is clear,…
Pen wastage and its effect on real cost Replied, post #24 · Access › Pricing · 12 Sep 2024 · 31 likes Wastage from a concentration choice that leaves an unusable remainder is a real cost and is invisible in a per-milligram figure. That is the shape of it. The detail is…
Progressive overload when the scale is falling — one year on Replied, post #18 · Nutrition & Training › Resistance training · 1 Sep 2024 · 0 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop.
Reporting a discrepancy without making an allegation Replied, post #14 · Sourcing › Vendor reports · 4 Aug 2024 · 21 likes Picking up post #11: that is the part I would want checked first. Where the reporting a discrepancy discussion usually stalls is that nobody wants to say "I do not…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #37 · Practice › Dosing & titration · 1 Aug 2024 · 22 likes Taking post #36 at face value and following it one step further. Practical answer on four-week escalation interval, since the theoretical one is upthread: do the…
The mass-error checker and its intended scope Replied, post #145 · Data & Tools › Calculators · 22 Jul 2024 · 0 likes Picking up post #144: that is the part I would want checked first. On mass-error checker the community has more anecdote than the confidence in this thread implies, and…
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #18 · Nutrition & Training › Resistance training · 25 Jun 2024 · 5 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum. Not the…